Oral Formulations - Live Webinar

  • 08 Oct 2019
  • 07:30 pm - 09:30 pm
  • Live Webinar,
  • $69.00 incl. GST for members
  • $92.00 incl. GST for non-members
  • Save to my calendar

About the event

This course is provided by College Education and Training, a business unit of Pharmaceutical Society of New Zealand Inc.

Presented by:

David Woods

David is an independent pharmaceutical consultant with extensive experience in pharmacy, education, medicines information, clinical pharmacy practice and research on compounded formulations for children. He was previously involved with the postgraduate program at the School of Pharmacy, University of Otago and participated in the medicines information papers since their inception.

He is now a part time Professional Teaching Fellow at the School of Pharmacy, University of Auckland. As a contractor David has worked with BPAC on various projects including management of the initial development and publication of the New Zealand Formulary.David works as an adviser and educator on rational medicines use and clinical pharmacy in several other countries including Oman, Kazakhstan, Brazil and Lithuania.

He is currently involved with pharmacovigilance research at BPAC and the New Zealand Pharmacovigilance Centre and works in practice as a clinical pharmacist in a multidisciplinary pain clinic. David has had a long term interest in assuring and promoting the safe and effective use of compounded medicines, especially for children and has advised nationally and internationally in this area.He chairs the Compounding Working Group which recently reviewed the standard formulations for use in New Zealand.

Course Information:

On completion of this course, pharmacists will be able to:

  • Explain the risks associated with compounding and administration of an oral liquid formulation, especially in the context of administration to children.
  • Apply the principles of risk assessment and risk minimisation for compounded formulations using practical examples
  • Explain the rationale for the creation standard batch sheets for use in New Zealand, including selection of appropriate bases, expiry dates and storage conditions.
  • Describe the alternatives to compounding oral liquid formulations from tablets and the situations that these could be applied.
  • Advise parent and caregivers on the safe and appropriate use of compounded oral liquids.


Pharmacists must achieve an 80% pass mark in order to complete the course.

One learning package must be purchased for each individual to complete the course.

Group 1 and 2 points are measured in "points per hour of learning" and will be confirmed by ENHANCE after the event.

Pre reading is not assessed. Allocate Group 1 points based on one point per hour.

Non Member Registration

Non PSNZ members can register for this event. Please note you will need to register as a user on the PSNZ website before you can register to attend the event. Look for the "New user? Register now" option at the bottom of the Login screen.

Cancellation and Refund Policy:

Payment must be received before your course materials will be made available to you. Confirmation and how to access the course materials will be forwarded to your preferred email address once your registration has been processed.

Registrations are subject to our terms of trade and privacy policy available at www.psnz.org.nz.

Cancellation more than seven days before the webinar:

A full refund is available. This amount may be refunded, or transferred to another course or another person.

Cancellation between two and seven days before the webinar:

A 50% refund is available. This amount may be refunded, or transferred to another course or another person.

Cancellation the day before, the day of, or after the webinar:

No refund available.

By submitting this application you agree to these terms and conditions.


By enrolling in this training, you are confirming that all work undertaken within this training programme and assessment answers are your own. If there are grounds to believe that cheating or plagiarism has occurred, we will investigate and your work may be disallowed and you will be unable to complete the training.